Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study
Abstract Background According to the World Health Organization, South Africa ranks as one of the highest burden of TB, TB/HIV co-infection, and drug-resistant TB (DR-TB) countries. DR-TB treatment is complicated to administer and relies on the use of multiple toxic drugs, with potential for severe a...
Main Authors: | Kathryn Schnippel, Rebecca H. Berhanu, Andrew Black, Cynthia Firnhaber, Norah Maitisa, Denise Evans, Edina Sinanovic |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2016-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-016-1933-0 |
Similar Items
-
Adverse Drug Reactions with First-Line and Second-Line Drugs in Treatment of Tuberculosis
by: Rajendra Prasad, et al.
Published: (2021-01-01) -
Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register
by: Kathryn Schnippel, et al.
Published: (2015-10-01) -
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01) -
Overview of drug-resistant tuberculosis worldwide
by: Ali A Velayati, et al.
Published: (2016-01-01) -
Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: a retrospective cohort study
by: Mehari Woldemariam Merid, et al.
Published: (2019-03-01)